Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|August 13, 2015
Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015Hardev Pandha, Graham PawelecAdvances in Cancer Research|December 13, 2006
Tumor antigens as surrogate markers and targets for therapy and vaccinesAngus Dalgleish, Hardev PandhaMethods in Molecular Biology (Clifton, N.J.)|January 2, 2025
Using the Conserved Hexapeptide in HOX Proteins as an Antagonist of HOX/PBX InteractionsRichard Morgan, Christopher Smith, Hardev PandhaInternational Journal of Cancer|May 18, 2010
Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agentsAgnieszka Michael, Kate Relph, Hardev PandhaGenes|July 29, 2025
A Subset of HOX Genes Negatively Correlates with HOX/PBX Inhibitor Target Gene Expression and Is Associated with Apoptosis, DNA Repair, and Metabolism in Prostate CancerRichard Morgan, Christopher Smith, Hardev PandhaJournal of Immunological Methods|December 31, 2002
Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transductionJustin John, James Hutchinson, Angus Dalgleish, et al.Expert Review of Vaccines|March 19, 2013
Prostate cancer vaccinesAgnieszka Michael, Kate Relph, Nicola Annels, et al.Thescientificworldjournal|March 9, 2010
Activation and genetic modification of human monocyte-derived dendritic cells using attenuated Salmonella typhimuriumAgnieszka Michael, Justin John, Brendan Meyer, et al.Frontiers in Oncology|March 6, 2020
Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic ResponseNicola E Annels, Guy R Simpson, Hardev PandhaSeminars in Oncology|December 13, 2005
Adenoviral strategies for the gene therapy of cancerKate Louise Relph, Kevin J Harrington, Hardev PandhaPageof 15